Home Other Building Blocks 2',4',6'-Trihydroxypropiophenone

2',4',6'-Trihydroxypropiophenone

CAS No.:
2295-58-1
Catalog Number:
AG002LNJ
Molecular Formula:
C9H10O4
Molecular Weight:
182.1733
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
95%
In Stock USA
United States
$32
- +
5g
95%
In Stock USA
United States
$75
- +
25g
95%
In Stock USA
United States
$215
- +
Product Description
Catalog Number:
AG002LNJ
Chemical Name:
2',4',6'-Trihydroxypropiophenone
CAS Number:
2295-58-1
Molecular Formula:
C9H10O4
Molecular Weight:
182.1733
MDL Number:
MFCD00016456
IUPAC Name:
1-(2,4,6-trihydroxyphenyl)propan-1-one
InChI:
InChI=1S/C9H10O4/c1-2-6(11)9-7(12)3-5(10)4-8(9)13/h3-4,10,12-13H,2H2,1H3
InChI Key:
PTHLEKANMPKYDB-UHFFFAOYSA-N
SMILES:
CCC(=O)c1c(O)cc(cc1O)O
EC Number:
218-942-8
UNII:
05V5NVB5Y1
Properties
Complexity:
180  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
182.058g/mol
Formal Charge:
0
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
182.175g/mol
Monoisotopic Mass:
182.058g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
77.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.6  
Literature
Title Journal
Self-assembled light-harvesting peptide nanotubes for mimicking natural photosynthesis. Angewandte Chemie (International ed. in English) 20120109
Facilitation of expulsion of ureteral stones by addition of α1-blockers to conservative therapy. Scandinavian journal of urology and nephrology 20101201
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Positively charged calcium phosphate/polymer nanoparticles for photodynamic therapy. Journal of materials science. Materials in medicine 20100301
Different measures of molecular mobility: comparison between calorimetric and thermally stimulated current relaxation times below Tg and correlation with dielectric relaxation times above Tg. Journal of pharmaceutical sciences 20081001
Prediction of onset of crystallization from experimental relaxation times. II. Comparison between predicted and experimental onset times. Journal of pharmaceutical sciences 20080101
Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition. Pharmaceutical research 20061001
Properties